Plain-English translation of NCT07139314 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
After a stroke caused by atrial fibrillation (irregular heartbeat), you may receive emergency treatment to remove the blood clot from your brain. This trial is testing when to start direct oral anticoagulants (DOACs)—a type of blood thinner medication—to help prevent another stroke. The question is whether starting this medication within 4 weeks or waiting until 4–8 weeks after your stroke is safer and more effective.
After emergency clot removal, some patients develop bleeding in the brain, which makes doctors cautious about starting blood thinners right away. This trial exists to find the safest timing for starting this medication so that you get the blood-thinning protection you need without increasing the risk of dangerous bleeding.
You likely qualify if…
You likely don't qualify if…
After you have recovered enough from your stroke (7 to 28 days after it occurred), you will be randomly assigned to start the blood thinner medication either within 4 weeks or between 4–8 weeks of your stroke. You will take the medication by mouth as directed and attend follow-up visits for 90 days. Researchers will monitor you for safety and track how well the treatment works in preventing another stroke while minimizing bleeding complications.
AI-generated summary from trial data · Jun 1, 2026 · Not medical advice
China